424 related articles for article (PubMed ID: 20699418)
1. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.
Wang XX; Jiang T; Shen Y; Caldas Y; Miyazaki-Anzai S; Santamaria H; Urbanek C; Solis N; Scherzer P; Lewis L; Gonzalez FJ; Adorini L; Pruzanski M; Kopp JB; Verlander JW; Levi M
Diabetes; 2010 Nov; 59(11):2916-27. PubMed ID: 20699418
[TBL] [Abstract][Full Text] [Related]
2. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
Wang XX; Wang D; Luo Y; Myakala K; Dobrinskikh E; Rosenberg AZ; Levi J; Kopp JB; Field A; Hill A; Lucia S; Qiu L; Jiang T; Peng Y; Orlicky D; Garcia G; Herman-Edelstein M; D'Agati V; Henriksen K; Adorini L; Pruzanski M; Xie C; Krausz KW; Gonzalez FJ; Ranjit S; Dvornikov A; Gratton E; Levi M
J Am Soc Nephrol; 2018 Jan; 29(1):118-137. PubMed ID: 29089371
[TBL] [Abstract][Full Text] [Related]
3. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
[TBL] [Abstract][Full Text] [Related]
4. The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria.
Wang XX; Jiang T; Shen Y; Adorini L; Pruzanski M; Gonzalez FJ; Scherzer P; Lewis L; Miyazaki-Anzai S; Levi M
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1587-96. PubMed ID: 19776172
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model.
Han SY; Song HK; Cha JJ; Han JY; Kang YS; Cha DR
Acta Diabetol; 2021 Apr; 58(4):495-503. PubMed ID: 33399988
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.
Gai Z; Gui T; Hiller C; Kullak-Ublick GA
J Biol Chem; 2016 Jan; 291(5):2397-411. PubMed ID: 26655953
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.
Slaughter TN; Paige A; Spires D; Kojima N; Kyle PB; Garrett MR; Roman RJ; Williams JM
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R727-34. PubMed ID: 23926133
[TBL] [Abstract][Full Text] [Related]
8. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.
Proctor G; Jiang T; Iwahashi M; Wang Z; Li J; Levi M
Diabetes; 2006 Sep; 55(9):2502-9. PubMed ID: 16936198
[TBL] [Abstract][Full Text] [Related]
9. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
[TBL] [Abstract][Full Text] [Related]
10. Effect of simvastatin on the expression of farnesoid X receptor in diabetic animal models of altered glucose homeostasis.
Wang L; Huang X; Hu S; Ma X; Wang S; Pang S
Chin Med J (Engl); 2014; 127(2):218-24. PubMed ID: 24438607
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
12. Lipid droplet accumulation is associated with an increase in hyperglycemia-induced renal damage: prevention by liver X receptors.
Kiss E; Kränzlin B; Wagenblaβ K; Bonrouhi M; Thiery J; Gröne E; Nordström V; Teupser D; Gretz N; Malle E; Gröne HJ
Am J Pathol; 2013 Mar; 182(3):727-41. PubMed ID: 23318573
[TBL] [Abstract][Full Text] [Related]
13. Arginase-2 mediates diabetic renal injury.
Morris SM; Gao T; Cooper TK; Kepka-Lenhart D; Awad AS
Diabetes; 2011 Nov; 60(11):3015-22. PubMed ID: 21926276
[TBL] [Abstract][Full Text] [Related]
14. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy.
Devaraj S; Tobias P; Kasinath BS; Ramsamooj R; Afify A; Jialal I
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1796-804. PubMed ID: 21617141
[TBL] [Abstract][Full Text] [Related]
15. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
Elmarakby AA; Faulkner J; Al-Shabrawey M; Wang MH; Maddipati KR; Imig JD
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1307-17. PubMed ID: 21832210
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
[TBL] [Abstract][Full Text] [Related]
17. Decorin deficiency enhances progressive nephropathy in diabetic mice.
Williams KJ; Qiu G; Usui HK; Dunn SR; McCue P; Bottinger E; Iozzo RV; Sharma K
Am J Pathol; 2007 Nov; 171(5):1441-50. PubMed ID: 17884968
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice.
Patel M; Wang XX; Magomedova L; John R; Rasheed A; Santamaria H; Wang W; Tsai R; Qiu L; Orellana A; Advani A; Levi M; Cummins CL
Diabetologia; 2014 Feb; 57(2):435-46. PubMed ID: 24201575
[TBL] [Abstract][Full Text] [Related]
19. IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice.
Kim KH; Hong GL; Jung DY; Karunasagara S; Jeong WI; Jung JY
Mol Med; 2021 Mar; 27(1):25. PubMed ID: 33691614
[TBL] [Abstract][Full Text] [Related]
20. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
